.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Integrating Prostate Cancer Trial Findings Into Practice: A Case-Based Discussion

EP. 1: Introduction: Review of CRPC Guideline Updates

June 11th 2015

EP. 2: Case Study: Treating High Risk CRPC

June 11th 2015

EP. 3: Role of Docetaxel in Newly Diagnosed Prostate Cancer

June 11th 2015

EP. 4: Initiation and Reintroduction of Docetaxel in Prostate Cancer

June 11th 2015

EP. 5: Case Study: Newly Diagnosed High-Risk Prostate Cancer

June 11th 2015

EP. 6: Importance of Detecting Early Metastasis in CRPC

June 11th 2015

EP. 7: Case Study: Newly Diagnosed Metastatic Prostate Cancer

June 11th 2015

EP. 8: Sequential and Combined Therapies in mCRPC

June 11th 2015

EP. 9: Case Study: Symptomatic, Progressing mCRPC

June 11th 2015

EP. 10: Performance Status in Progressive mCRPC

June 11th 2015